The study incudes 18 to 55 y/o healthy subjects with moderate hair loss stage and Fitzpatrick skin type 5 or 6
Male and females between 21 - 55 years of age, inclusive.
Have Fitzpatrick Skin Type V to VI.
Have mild to moderate hair loss (Ludwig scale I-II for women, Norwood-Hamilton scale I-III for males)
Have self-reported thinning or hair loss for more than 6 months prior to screening but less than 5 years.
Clinical diagnosis of alopecia areata or scarring forms of alopecia
Patient is of skin type I-IV
Scalp hair loss on the treatment area, due to disease, injury, or medical therapy
Subjects who are pregnant, planning to become pregnant or breastfeeding. A urine pregnancy test will be done to rule out pregnancy. Subjects of childbearing potential who are not using an approved method of birth control (oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide or abstinence). Females of non-childbearing potential are defined as postmenopausal (e.g.: absence of menstrual bleeding for one year), hysterectomy or bilateral oophorectomy